BMRN vs H · P/E 40, rev $1.76B vs rev $3.58B
Biomarin Pharmaceutical Inc (BMRN) versus Hyatt Hotels Corporation (H) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Hyatt Hotels Corporation (H) is a lodging company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported H revenue for 2026-06-30 was $3.58B. Net income was $148.0M. H currently screens at market cap $17.08B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. H currently screens at market cap $17.08B.
Not investment advice. Open the BMRN and H stock pages for the full models.
Not investment advice.